Axsome Therapeutics Provides Year End 2018 Clinical Update

Posted December 27, 2018 by CognitionDev

filed under: Nasdaq

In the News

Oct 2, 2019

Axsome Therapeutics to Provide Update on Continued Progress at the 2019 Cantor Global Healthcare Conference

Sep 5, 2019

Axsome Therapeutics Presents Positive AXS-07 Phase 1 Trial Results at the 19th Congress of the International Headache Society

Sep 3, 2019

Axsome Therapeutics to Present at the Morgan Stanley 17th Annual Global Healthcare Conference

See All News